0.5014
price up icon10.20%   0.0464
after-market Dopo l'orario di chiusura: .52 0.0186 +3.71%
loading
Precedente Chiudi:
$0.455
Aprire:
$0.4402
Volume 24 ore:
2.11M
Relative Volume:
1.23
Capitalizzazione di mercato:
$19.67M
Reddito:
$3.04M
Utile/perdita netta:
$-33.97M
Rapporto P/E:
-0.377
EPS:
-1.33
Flusso di cassa netto:
$-52.47M
1 W Prestazione:
+20.27%
1M Prestazione:
+0.93%
6M Prestazione:
-66.57%
1 anno Prestazione:
-82.41%
Intervallo 1D:
Value
$0.4402
$0.5046
Intervallo di 1 settimana:
Value
$0.401
$0.5046
Portata 52W:
Value
$0.387
$3.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Nome
Rani Therapeutics Holdings Inc
Name
Telefono
(408) 457-3700
Name
Indirizzo
2051 RINGWOOD AVENUE, SAN JOSE
Name
Dipendente
106
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
RANI's Discussions on Twitter

Confronta RANI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
0.5014 19.83M 3.04M -33.97M -52.47M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-02 Iniziato Oppenheimer Outperform
2024-06-14 Iniziato Maxim Group Buy
2024-06-13 Iniziato Rodman & Renshaw Buy
2023-04-17 Ripresa BTIG Research Buy
2022-10-11 Iniziato UBS Buy
2022-07-27 Iniziato H.C. Wainwright Buy
2022-06-13 Iniziato Wedbush Outperform
Mostra tutto

Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Rani Therapeutics Holdings Inc. stockTremendous growth potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Rani Therapeutics Holdings Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Rani Therapeutics Holdings Inc. a good long term investmentConsistent triple-digit returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Rani Therapeutics Holdings Inc. stock priceBreakthrough investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser

Jul 22, 2025
pulisher
Jul 17, 2025

Rani Therapeutics Announces New Securities Purchase Agreement - The Globe and Mail

Jul 17, 2025
pulisher
Jul 15, 2025

Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Rani Therapeutics Holdings Inc. stock price move sharplyLong Term Low Risk Growth - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Rani Therapeutics Holdings Inc. stock performs during market volatility10x Return With Managed Risk - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics secures $3 million through registered direct offering - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews

Jul 15, 2025
pulisher
Jul 15, 2025

Rani Therapeutics (NASDAQ:RANI) Shares Up 8.4% – Here’s What Happened - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

The Psychology of Rani Therapeutics Holdings Inc Inc. (RANI) Price Performance: Understanding Market Sentiment - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

Rani Therapeutics stock soars after announcing ENDO 2025 presentation - Investing.com

Jul 14, 2025
pulisher
Jul 14, 2025

Rani Therapeutics stock soars after announcing ENDO 2025 presentation By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Rani Therapeutics Surges on Game-Changing Oral Drug Delivery News - RagingBull

Jul 14, 2025
pulisher
Jul 14, 2025

Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 14, 2025
pulisher
Jul 14, 2025

Rani Therapeutics to Present Preclinical Data on RaniPill® Capsule at ENDO 2025 Conference - Nasdaq

Jul 14, 2025
pulisher
Jul 14, 2025

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery - GlobeNewswire

Jul 14, 2025
pulisher
Jul 14, 2025

Revolutionary Oral GLP-1 Delivery System Matches Injectable Performance: RaniPill's Game-Changing Study Results - Stock Titan

Jul 14, 2025

Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):